BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 964 filers reported holding BAXTER INTL INC in Q2 2017. The put-call ratio across all filers is 0.35 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $122,000 | +23.2% | 1,501 | +0.1% | 0.03% | +3.8% |
| Q4 2018 | $99,000 | 0.0% | 1,500 | +16.4% | 0.03% | +13.0% |
| Q3 2018 | $99,000 | -48.2% | 1,289 | -50.1% | 0.02% | -50.0% |
| Q2 2018 | $191,000 | +13.7% | 2,582 | +0.1% | 0.05% | +15.0% |
| Q1 2018 | $168,000 | -37.3% | 2,580 | -39.5% | 0.04% | -42.0% |
| Q3 2017 | $268,000 | +3.9% | 4,266 | +0.1% | 0.07% | 0.0% |
| Q2 2017 | $258,000 | +16.7% | 4,260 | +0.1% | 0.07% | +7.8% |
| Q1 2017 | $221,000 | +14.5% | 4,254 | -2.5% | 0.06% | +10.3% |
| Q4 2016 | $193,000 | -13.5% | 4,363 | -6.9% | 0.06% | -13.4% |
| Q3 2016 | $223,000 | -51.0% | 4,685 | -53.4% | 0.07% | -52.8% |
| Q2 2016 | $455,000 | +3.9% | 10,059 | -5.7% | 0.14% | -6.6% |
| Q1 2016 | $438,000 | +23.7% | 10,664 | -1.0% | 0.15% | +9.4% |
| Q3 2015 | $354,000 | -60.0% | 10,770 | -15.0% | 0.14% | -59.1% |
| Q2 2015 | $886,000 | +86.1% | 12,676 | +82.4% | 0.34% | +82.8% |
| Q1 2015 | $476,000 | – | 6,951 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GENERATION INVESTMENT MANAGEMENT LLP | 21,171,371 | $1,817,350,000 | 7.47% |
| Soditic Asset Management LLP | 147,620 | $12,672,000 | 6.53% |
| NUANCE INVESTMENTS, LLC | 4,084,218 | $350,589,000 | 6.17% |
| PRAGMA GESTAO DE PATRIMONIO LTD | 145,000 | $12,447 | 5.96% |
| Veritas Asset Management LLP | 12,222,261 | $1,049,159,000 | 5.89% |
| Pavadi Capital LLC | 72,782 | $6,248,000 | 4.74% |
| Sonen Capital LLC | 48,907 | $4,198,000 | 4.06% |
| Glenview Capital Management | 2,182,422 | $187,339,000 | 3.99% |
| Dash Acquisitions Inc. | 103,963 | $8,924,000 | 3.87% |
| Avidity Partners Management LP | 1,765,000 | $151,508,000 | 3.21% |